If you are eligible to take part in our research, a member of our medical research team will contact you directly.
Advancing Health, Right Here in Our Community!
We’re excited to share that Linthorpe Surgery is now officially a research practice!
This means some of our patients may be invited to take part in NHS-approved research projects.
Why take part?
- Access to breakthrough treatments that may be years away from general release
- Help tackle local health inequalities
- Contribute to the future of medicine
Our First Project
We’re launching a study into a new medication that may help prevent heart failure. You could be part of pioneering progress in heart health.
Meet Our Research Team
A dedicated research team is now working from our practice. They’ll contact you if you’re eligible to participate in any upcoming projects.
- Rachel Kipling: Clinical Research Practitioner, Study Coordinator
- Dr Helen Tucker: Research Physician, Sub-Investigator.
Participation is always voluntary and fully confidential
Thank you for supporting the future of healthcare. Together, we can make a difference!
Download this information as a poster (PPTX)
Cardiovascular disease? Let’s reduce the risks together
Consider joining a clinical study
If you have high blood pressure, diabetes and cardiovascular disease, our clinical study could be a good fit for you. While lifestyle changes and current medicines offer some protection, many people with these conditions still experience disease progression that increases their risk of further cardiovascular complications and kidney damage.
That’s why we’re running a global clinical study called EASi-PROTKT™ that aims to find out whether combining an investigational medicine with an approved medicine called empagliflozin could help people reduce their risk of developing serious heart health events, including heart failure, in the future.
What will taking part in this study involve?
If you’d like to take part, we’d first carry out some screening assessments to make sure that you and the study are a good fit.
If you’re eligible and choose to join, you’ll be randomly assigned to one of two groups.
GROUP 1:
- You’ll be given the investigational medicine and empagliflozin daily
GROUP 2:
- You’ll be given a placebo (a tablet that looks like the investigational medicine but contains no active medicine) and empagliflozin daily
You’ll be asked to take your assigned study medicines as two oral tablets daily for between 2.5 and up to 4.25 years. Your health
and well-being will be closely monitored throughout the study with scheduled study centre visits and telephone calls. Health
assessments will include: physical examinations, electrocardiograms (ECGs), and blood and urine samples. This health monitoring, along with the study medicines, will be provided at no cost to you.
You will receive reimbursement for travel costs and accommodation (if required), in line with local regulations.
Participation is entirely voluntary and if you join the study, you may leave at any time with no impact on your regular healthcare.